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The responsiveness of natural killer (NK) cells is controlled by balancing signals from acti-
vating and inhibitory receptors. The most important ligands of inhibitory NK cell receptors
are the highly polymorphic major histocompatibility complex (MHC) class I molecules,
which allow NK cells to screen the cellular health of target cells. Although these inhibitory
receptor–ligand interactions have been well characterized, the ligands for most activating
receptors are still unknown. The mouse cytomegalovirus (MCMV) represents a helpful
model to study NK cell-driven immune responses. Many studies have demonstrated that
CMV infection can be controlled by NK cells via their activating receptors, but the exact
contribution of the different signaling potential (i.e., activating vs. inhibiting) remains puz-
zling. In this study, we have developed a probabilistic model, which predicts the optimal
specificity of inhibitory and activating NK cell receptors needed to offer the best protec-
tion against a CMV-like virus. We confirm our analytical predictions with an agent-based
model of an evolving host population. Our analysis quantifies the degree of protection of
each receptor type, revealing that mixed haplotypes (i.e., haplotypes composed of acti-
vating and inhibiting receptors) are most protective against CMV-like viruses, and that the
protective effect depends on the number of MHC loci per individual.
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INTRODUCTION
Natural killer (NK) cells contribute to the host immune response
by recognizing and killing viral-infected and tumor cells (1). Their
activity is controlled by balancing signals from a vast repertoire of
activating and inhibiting receptors enabling them to distinguish
healthy from unhealthy cells (2). The most important ligands for
inhibitory NK cell receptors (iNKR) are MHC class I molecules on
other cells. An infected cell may have lower MHC expression, alter-
ing the binding with inhibitory receptors, disrupting the balance
of signals, and allowing for NK cell activation. The mechanism by
which NK cells attack MHC class I deficient cells was coined by
Kärre et al. as “missing-self” detection (3).
There are several NKRs that contribute to missing-self
detection. In humans, for example, the inhibitory receptor
CD96/NKG2A binds to complexes of the human leukocyte
antigen-E (HLA-E), which presents peptides derived from the
leader sequences of HLA-A, -B, and -C molecules (4, 5). Both the
receptor and the ligand are highly conserved in these inhibitory
interactions, and the down-stream effects are remarkably similar
across individuals (6). The killer immunoglobulin-like receptors
(KIRs) also contribute to monitor abnormalities in MHC class I
expression on cell surfaces. In contrast to the CD96/NKG2 super-
family, KIRs are highly polygenic and polymorphic, exhibit both
inhibitory and activating potential, and bind to the highly poly-
morphic HLA-A, -B, and -C molecules (7–9). Consequently, the
interactions between KIRs and classical HLA-class I molecules are
very diverse (10). Thus, humans have two types of NKRs, one
conserved and one highly diverse, performing seemingly the same
function.
Humans are not the only species that have an expanded and
polymorphic NKR gene complex. During mammalian radiation,
many different species have diversified alternative NKR gene fam-
ilies recognizing MHC class I. This example of convergent evolu-
tion includes three gene families from two structurally unrelated
superfamilies: KIRs, the CD94/NKG2, and the Ly49 (11). Higher
primates have expanded their KIR genes (12); a group of lower
primates have expanded NKG2 (13), whereas rodents and equids
have expanded Ly49 (14, 15). These alternative genetic strategies
illustrate the evolutionary complexity of these systems, and sug-
gest that an expanded NKR gene complex is beneficial for survival.
But, if conserved inhibitory receptor–ligand interactions (such
as NKG2A–HLA-E in humans) are capable to successfully detect
missing-self, why have several NKR families evolved to become
polygenic and polymorphic? Even more intriguing, why have they
evolved receptors with activating potential?
In humans, some activating NKRs (aNKRs) are associated with
the disease outcome of viral infections and malignancies (16). For
example, in combination with HLA–Bw4, the activating KIR3DS1
has been associated with a delayed progression to AIDS in HIV-1
infected individuals (17, 18). KIR3DS1 has also been linked to an
increased rate of spontaneous recovery after hepatitis B infections
(19), a reduced risk of developing hepatocellular carcinoma in
patients infected with HCV (20), and a reduced risk of Hodgkin’s
lymphoma (21). Moreover, maternal activating KIRs are related to
protection against several pregnancy disorders (22). But because
only a few ligands for activating KIRs have been identified so
far, the exact mechanisms underlying the provided protection in
humans remain puzzling.
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Studies in mice have revealed important insights into the role
of aNKR during viral infections (23, 24). Viruses like the mouse
cytomegalovirus (MCMV) down-regulate the expression of MHC
class I molecules from the cell surface to escape T cell response,
and may additionally code decoy MHC molecules (m157) that
can inhibit NK cell activation (23). Mouse strains that are resis-
tant to MCMV carry the activating Ly49H gene, which binds with
high affinity to the MHC-like viral protein m157. In contrast,
mice susceptible to MCMV lack the activating gene but carry the
inhibiting receptor Ly49I, which also binds strongly to the m157
protein. The activating Ly49H emerged from an inhibitory coun-
terpart (25), suggesting that the evolution of an aNKR was due to
the immune pressure induced by the “MHC decoy” m157 during
CMV infection (26, 27).
Although these studies shed light into the importance of NKR
in general, the specific contribution of activating and inhibitory
receptors to the NK cell response is still unknown. We previously
studied the evolution of KIR diversity in a human population
infected with CMV-like viruses by using a computational agent-
based model (28). We showed that iNKRs require sufficient speci-
ficity to protect populations against viruses evolving MHC-like
molecules, and that diversity in the NK cell genetic complex evolves
as a result of the required discrimination between self-MHC mol-
ecules and viral decoy molecules. Here, we also consider aNKRs,
and develop a probabilistic model to quantify the optimal speci-
ficity of inhibitory and activating NKRs needed to render maximal
protection against CMV-like viruses. We also analyze the effect of
mixed haplotypes (i.e., composed of aNKR and iNKR) on pro-
tection, and confirm the expectations of the probabilistic model
with an agent-based computational model. Our studies reveal that
mixed haplotypes composed of specific activating and inhibitory
NKRs render high protection against CMV-like viruses encoding
for decoy molecules, and that the protective effect depends on the
number of MHC loci per individual.
RESULTS
We analyze the effect of the specificity of activating and inhibitory
NKRs on the detection of a virus presenting MHC-like molecules
with a simple probabilistic model. Our model estimates the chance
of protection P, i.e., the probability of a host detecting an infection
by NK cells, as a function of the haplotype size, specificity (i.e., the
probability p of recognizing any random MHC molecule), and
number of MHC loci.
The responsiveness of NK cells (i.e., their ability to discriminate
cells with normal MHC expression from those lacking MHC) is
regulated by a process called“education”or“licensing”taking place
during NK cell development (29). During this process, the inter-
actions of iNKRs with their MHC ligands render the NK cells with
functional competence (13, 29, 30). To prevent NK cell-related
autoimmunity, activating receptors also participate in the educa-
tion process, where the chronic exposure of aNKR ligands during
development results in hyporesponsive NK cells (31, 32).
For simplicity, we do not model individual NK cells, each
expressing a random set of tuned receptors. We rather consider
for each individual a global repertoire of receptors, which have
the potential to license NK cells. Henceforth, we will refer to these
receptors as “licensed” receptors. We mimic the MHC-dependent
NK cell
MHC Class I
RKNaRKNi
licensed iNKR unlicensed iNKR unlicensed aNKR licensed aNKR
FIGURE 1 | Cartoon of NK cell education. iNKRs (represented in red)
recognizing at least one of the MHC molecules per individual will become
licensed. In contrast, aNKRs (depicted in green), which do not recognize
any of the host’s MHC molecules will become licensed.
education process during NK cell development by creating a reper-
toire of NKRs composed of iNKRs that recognize at least one of
the MHC molecules of the host, and of aNKRs that recognize
none of the MHC molecules of the host (Figure 1). By consider-
ing a global repertoire, we assume that there will be at least one
subset of NK cells expressing at least one of the “licensed” NKRs.
Upon infection, we consider only those NK cell subsets having
licensed receptors. If these can successfully detect the virus, they
will become activated, expand, and protect (see Appendix for a
full discussion). Therefore, only the licensed repertoire of NKRs is
allowed to participate in the immune response.
Whether a decoy protein allows a virus to successfully escape
the NK response, i.e., whether that individual is protected against
the infection, depends on the receptor type and on the recep-
tor specificity. iNKRs that bind the decoy molecule cannot detect
missing-self and are “fooled” by the decoy. Conversely, aNKRs
binding the foreign decoy protein can specifically recognize the
infection and therefore protect the host. With this model, we quan-
tify the contribution of each receptor type and its specificity to the
detection of CMV-like viruses.
INHIBITORY AND ACTIVATING NK CELL RECEPTORS DIFFER IN THE
PROTECTION LEVEL THEY PROVIDE
There are two crucial processes for a single iNKR to detect virus
evolving MHC-like molecules. First, iNKRs have to be licensed
during the NK cell education to become fully functional dur-
ing an immune response. Second, iNKRs should not bind decoy
molecules upon infection. Because, in our model, iNKRs are only
licensed if they recognize at least one of the MHC molecules in
their host, and decoy molecules are similar to self-MHC molecules,
iNKRs face the challenge of distinguishing self-MHC molecules
from foreign decoy molecules. We previously demonstrated that
this challenge can be solved by evolving sufficiently specific iNKRs
(28). In that study, we defined specificity as the probability (p) of
any NKR to recognize a random MHC molecule in the popula-
tion. Herewith, degenerate receptors (i.e., with p= 1) are able to
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recognize all MHC molecules in the population, whereas specific
receptors (i.e., with p∼ 0) recognize only a small fraction of them.
Since the exact relation between ligand–receptor binding affinity
and signaling potential remains unknown, we do not consider dif-
ferent binding affinities here, and we model discrete MHC–NKR
interactions.
To study whether there is an optimal specificity for which
iNKRs are not inhibited by such “decoy viruses,” we calculated
the probability of licensed iNKRs detecting the infection. A single
iNKR becomes licensed with a probability qI = 1−(1− pI)2NMHC ,
where pI describes the specificity (i.e., the probability of any iNKR
to recognize any MHC in the population), and N MHC the num-
ber of MHC loci per individual. The probability of a haplotype
composed of N iNKR to have exactly licensed iNKRs is given by the
binomial distribution as follows:
P (iNKRlicensed = `) =
(
NiNKR
`
) (
1− qI
)NiNKR−`q`I . (1)
To successfully detect a decoy virus, none of the licensed iNKRs
should bind the decoy molecule. Thus, the overall probability of
detecting the infection is determined by the chance that none
of the licensed iNKRs recognizes a decoy molecule, and can be
calculated by:
PI (detection) =
NiNKR∑
`=1
(
NiNKR
`
) (
1− pI
)`(
1− qI
)NiNKR−`q`I .
(2)
Our analysis confirms that for any haplotype size, there is an
optimal specificity. For N iNKR≤ 25, our model predicts a maxi-
mal level of protection (i.e., P I= 0.85), which can only be obtained
with high specificity values (pI≤ 0.2) and a large number of genes
per haplotype (N iNKR≥ 20) (Figure 2A).
A host with degenerate iNKRs (e.g., pI≥ 0.8) has a large reper-
toire of licensed iNKRs. But because of the low specificity, the
iNKRs within that individual are expected to also recognize any
foreign decoy molecule as self, offering no protection. In con-
trast, when iNKRs are specific (e.g., pI≤ 0.2) the repertoire of
licensed iNKRs per individual is lower, but if there are several
genes per haplotype, the chance of having at least one licensed
specific iNKR increases. Due to their high specificity, it is unlikely
for a licensed iNKR to also recognize a foreign decoy molecule,
impeding the virus to escape the NK immune response. There-
fore, an infection with a decoy virus can be controlled with a
probability of at least 70% in a haplotype composed of more
than 10 iNKRs when pI≤ 0.25. Thus, the probability of detect-
ing the virus increases with both a higher specificity and a larger
number of genes per haplotype (i.e., N iNKR). This confirms our
previous results, suggesting that large haplotypes composed of
non-overlapping specific iNKRs are most protective (28).
We next developed a model considering only aNKRs. Similar
to the iNKRs, the two crucial processes for an aNKR to detect the
virus depends on the probability of becoming licensed and rec-
ognizing the decoy molecule as a foreign antigen. However, the
licensing process is almost opposite between aNKRs and iNKRs.
An aNKR becomes licensed if it does not recognize any MHC
molecule within an individual. The probability of a single aNKR
to become licensed is therefore described by qA = (1− pA)2NMHC ,
where pA is the specificity of an aNKR. Opposite to an iNKR, an
aNKR detects a “decoy virus” if it binds the MHC decoy. Thus, the
overall probability of protection in this case is determined by the
chance of at least one licensed aNKR binding the decoy molecule,
and is given by:
PA (detection) =
NaNKR∑
`=1
(
NaNKR
`
)(
1− (1− pA)`)
× (1− qA)NaNKR−`q`A, (3)
where N aNKR is the number of aNKRs per haplotype.
This model reveals that there is again an optimal specificity,
and the protection range for aNKR is much broader than that
for iNKR, covering also less specific receptors (i.e., 0.1≤ pA≤ 0.7)
(Figure 2B). In these cases, the optimal protection (i.e., PA= 1) is
obtained with haplotypes composed of 12 genes, having interme-
diate specificity values (0.2≤ pA≤ 0.65). To avoid self-reactivity,
aNKRs become licensed only if they fail to recognize all self-
MHC molecules. Additionally, an aNKR must recognize foreign
MHC-like molecules to detect the infection. Therefore, the chal-
lenge for an aNKR is opposite to that of an iNKR, since it must
recognize foreign antigens but not self-MHC molecules. A degen-
erate aNKR will recognize every decoy in the population but it
will never become licensed. As a result, the optimal protection is
reached in large haplotypes composed of aNKRs with intermediate
specificity.
Note that we consider individuals to be heterozygous for all
MHC loci. Allowing individuals to be homozygous in some MHC
loci does not qualitatively change our results on specificity and
protection, since MHC homozygosity has only a mild effect on the
number of licensed receptors, ` (results not shown).
THE PROTECTION LEVEL DEPENDS ON THE NUMBER OF MHC LOCI
Above, we considered only one MHC locus per individual as a rep-
resentation of HLA-C as the main identified ligand for inhibitory
KIRs. However, HLA-A and -B molecules have also been identi-
fied as KIR ligands, and HLA-E is the ligand for CD94/NKG2A.
Therefore, we expanded our model to consider two MHC loci per
individual. The distribution of protection levels is similar to the
model with one MHC locus, showing a small protective area for
individuals carrying only iNKRs (Figure 2C), whereas individu-
als carrying aNKRs have a broader protective range (Figure 2D).
However, the area of maximal protection is skewed in both cases.
Because iNKRs have to recognize at least one self-MHC molecule
to become licensed, the chance of having several licensed NKRs per
haplotype increases by having 2 MHC loci (and thus 4 MHC mol-
ecules per heterozygous individual). Therefore, a high protection
(e.g., P I≥ 0.85) can be reached already with a smaller haplotype,
e.g., one composed of at least 11 iNKRs.
In contrast, the probability of an aNKR to become licensed
decreases with 2 MHC loci because aNKRs should not recognize
any of the MHC molecules within an individual. Consequently,
the protection with aNKRs reaches high values (i.e., PA≥ 0.85)
only with large haplotypes composed of at least 20 genes and
the optimal protection level (PA= 1) is never obtained. Thus, the
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FIGURE 2 | Range of protection differs between iNKRs and aNKRs.
The heatmaps show the protection level as the probability of detecting
the infection with a virus expressing a decoy molecule to mask MHC
down-regulation. In the left column, the protection for individuals
carrying only iNKRs [calculated by equation (2)] is shown, whereas in
the right column, the protection for individuals carrying only aNKRs
[calculated by equation (3)] is depicted. The protection level is shown in
the color bar from highest (red) to lowest (blue). pi and pa correspond to
the specificity of iNKR and aNKR, respectively. (A,B) The protective
range for iNKRs is small and skewed toward a large haplotype size and
high specific values. In contrast, aNKRs offer a broad range of
protection for intermediate specificity values and a smaller haplotype
size. Calculations were done with 1 MHC locus (A,B), 2 MHC loci
(C,D), and 4 MHC loci (E,F).
protection of aNKRs is highly dependent on the number of MHC
molecules per individual.
With even higher MHC complexity, i.e., by increasing the num-
ber of MHC loci per individual to 4, fewer iNKRs are sufficient to
successfully clear the infection (Figures 2E,F). Because of the edu-
cation process in our model, hosts with 4 MHC loci have a much
larger licensed iNKR repertoire compared to individuals having
1 MHC locus. These hosts reach the maximal protection already
with a haplotype size of 4 receptors. Even for lower haplotype
sizes, a good protection level (i.e., 0.3≤ P I≤ 0.7) can be reached
at lower specificity values (pI≤ 0.35) (Figure 2E). This effect was
further increased when considering 8 MHC loci per individual,
where the maximal protection was reached with only one specific
iKIR (results not shown).
However, an expanded MHC haplotype is disadvantageous for
individuals having only aNKRs. Because in our model the licensing
process is more difficult with a higher number of MHC molecules,
little protection can be provided. The infection can be controlled
Frontiers in Immunology | T Cell Biology January 2014 | Volume 5 | Article 20 | 4
Carrillo-Bustamante et al. Quantifying the protection of NKRs
with a maximal probability of 50 and 35% in individuals with 4
(Figure 2F) and 8 MHC loci (results not shown), respectively.
Taken together, these results show that aNKRs provide little
protection against a virus evolving MHC decoy proteins in individ-
uals having several MHC loci, and that a contracted haplotype of
iNKRs is already protective when the MHC complexity increases.
VIRAL DETECTION IS MAXIMAL IN MIXED HAPLOTYPES
To predict the combined protection of activating and inhibitory
NKRs, we expanded our model and considered mixed haplotypes,
i.e., haplotypes composed of both iNKRs and aNKRs. We predict
the combined probability of detecting the virus as follows:
P = 1− (1− PI) (1− PA) . (4)
We computed the protection in hosts carrying two MHC and 20
NKR loci, and varied the fraction of aNKRs in the NKR haplotype,
while keeping the total number of loci constant. The best protec-
tion is reached in mixed haplotypes (Figure 3). As seen above, hap-
lotypes with aNKRs only provide protection (i.e., 0.5≤ P ≤ 0.8)
for intermediate specificity values 0.15≤ pA≤ 0.4 (Figure 3A).
With increasing number of iNKRs per haplotype, the protection
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FIGURE 3 | Mixed haplotypes render highest protection. The heatmaps
show the protection level as the probability of detecting the infection for
haplotypes composed of iNKRs and aNKRs [as calculated by equation (4)].
The protection level is shown in the color bar from highest (red) to lowest
(blue). (A–F) Show the NKR haplotype composition for different fractions
of iNKR and aNKR. Considering a haplotype size of NNKR =20, we first
modeled haplotypes composed of aNKRs only (A), and reduced their
number, while increasing the number of iNKRs (B–E), until we obtained a
haplotype composed only of iNKRs (F). We here consider 2 MHC loci (i.e.,
NMHC =2).
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reaches higher values (approaching P = 1) (Figures 3B,C), cover-
ing a larger range of specificity values and having a skewed distri-
bution toward more specific inhibitory and activating receptors.
A large number of iNKRs per haplotype reduces the contribution
of aNKRs, and therefore the latter can have low specificity values
without affecting the protection level (Figures 3D,E). Note that
the area of high protection shrinks when the fraction of aNKRs
is decreased, where maximal protection can only be achieved for
extremely high specificities (i.e., pI≤ 0.1) (Figure 3F).
These results depend on a similar manner on the number of
MHC loci per individual as those shown in Figure 2, with aNKRs
having a lower protective effect with increasing MHC loci num-
ber (results not shown). Therefore, we conclude that the maximal
protection against CMV-like viruses is easier to achieve in mixed
haplotypes.
AGENT-BASED MODEL OF ACTIVATING AND INHIBITORY NKRs
Our probabilistic model allows us to quantify the expected pro-
tection, given a certain number of aNKRs and iNKRs. However,
it is not clear whether a population with evolving NKRs would
find the same basin of attraction for the specificity (i.e., p) when
infected with a CMV-like virus.
To study the evolution of NKR specificity in populations
infected with a CMV-like virus, we developed an agent-based
model similar to the one published in Ref. (28) (for a detailed
description of the model, see Materials and Methods). Briefly, our
model considers a human population infected with a non-lethal
herpes-like virus causing chronic infections. The hosts carry a
diploid genome with one or two MHC loci and ten NKR loci.
We consider 15 MHC alleles per locus (mimicking the common
HLA-B and -C alleles in the European populations) and this poly-
morphism is kept constant throughout the entire simulation (i.e.,
we do not allow for mutation of the MHC genes). The initial NKR
haplotype consists of ten different genes, and all individuals are
homozygous for the same NKR haplotype.
Upon birth, novel receptors can be created, allowing for evolu-
tion within the NKR gene complex. Each new receptor comes with
a randomly chosen receptor type (i.e., either inhibitory or activat-
ing) and a randomly chosen specificity value (corresponding to
0≤ p≤ 1, see Materials and Methods). Receptors are so specific
that they are unable to recognize any MHC in the population will
never be functional, and are considered to be pseudogenes. Thus,
haplotypes expand by acquiring receptors with novel p values and
signaling potential, but can also contract due to the accumulation
of pseudogenes.
In this agent-based model, we also mimic the MHC-dependent
NK cell education process (Figure 1). We remove iNKRs which
fail to recognize any MHC molecule within an individual from the
licensed repertoire. Similarly, those aNKRs capable of recogniz-
ing self-MHC molecules are deleted from the licensed repertoire.
Only the licensed NKRs are able to participate during the immune
response.
Infection of a host starts with a short acute phase, after which
the individual either recovers or becomes chronically infected. We
consider one wild-type virus and several decoy viruses (1 decoy
per MHC molecule in the population). We do not allow for super-
infection nor co-infection, thus hosts can be infected with only
one of the viruses. A decoy virus down-regulates the expression of
all MHC molecules within an individual, and expresses an MHC-
like molecule. Thus, every virus expressing a decoy molecule has
the potential to escape the immune response of both T and NK
cells. The evolution of decoy proteins is modeled by allowing the
virus to adopt a randomly selected MHC molecule from its host.
Therefore, each decoy protein is actually an MHC molecule.
The population is first inoculated with the wild-type virus,
which can be typically cleared after the acute phase because of
the implicit response of both T and NK cells. We model the
immune response with one parameter describing the probabil-
ity of clearing the infection. For the wild-type virus, this is
set to pwt= 0.85 (Table 1), resulting in approximately 85% of
the wild-type infections being cleared. Individuals clearing the
infection become immune for a period t i of 10 years. At steady
state, approximately 20% of the population becomes chronically
infected (Figures 4A,B; green solid lines), 65% become immune
(Figures 4A,B; green dashed lines), and 5% are susceptible for
infection. The immune escape of the decoy viruses is modeled by
decreasing the clearance probability to zero (pdec,1= 0, Table 1),
which occurs if at least one of the licensed iNKRs or none of
the aNKRs binds to the decoy molecule (Table 2). With this
agent-based model, we can study the evolution of NKR specificity,
and quantify the protection provided by activating and inhibitory
receptors.
INHIBITORY RECEPTORS EVOLVE HIGHER SPECIFICITY THAN
ACTIVATING RECEPTORS AFTER A CMV-LIKE INFECTION
We first study the protection provided by iNKRs against a CMV-
like virus. After 5000 years of infection with the wild-type virus,
we allow for the emergence of decoy viruses. The initial speci-
ficity of the iNKRs is set to p≈ 0.4 (see Materials and Methods).
The decoy viruses spread easily among individuals carrying only
iNKRs, resulting in a high fraction of chronically infected indi-
viduals (Figure 4A; red solid lines). Moreover, almost none of the
hosts is able to control the infection (Figure 4A; red dashed lines),
and the total population size decreases dramatically to 50% of the
carrying capacity (i.e., maximal population size), confirming the
results from the probabilistic model. However, after centuries of
infection, the fraction of recovered individuals increases, and with
it the total population size, indicating a recovery of the population.
This observation is consistent in all ten simulations we performed
for iNKRs (Figures 4A,C).
To study how these individuals evolve to control an infection
with a virus having an MHC-like molecule, we analyze the average
specificity of the NKRs over time. We determine how many MHC
molecules in the population can be recognized by each receptor,
and normalize it by the number of total MHC molecules in the
population (Figure 4E; red line). We observe that the specificity
increases after the emergence of the decoy viruses. At the end of the
simulations, each iNKR recognize <20% of the MHC molecules
in the population, indicating that evolution selects for specific
iNKRs.
We perform the same simulations and analysis for popula-
tions having only aNKRs. Compared to populations having iNKRs,
the initial spread of the virus is somewhat impaired (Figure 4B;
red solid lines). Already at the beginning of the infection, some
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Table 1 | Parameters of the agent-based model.
Parameter Value
Time step 1 week
Simulation time 2 Million years
HOST PARAMETERSa
Maximal population size, Nmax 5000 Individuals
MHC diversity 1–2 Loci, each with 15 alleles
Number of NKR loci 5–10
Bit string length 16 Bitsb
Host mutation rate, µ 0.00005 Per gene per birth
event
INFECTIONc
Infection state, i 1 (Acute), 2 (chronic)
Effect of viral load on the death rate,
VLi
0.1 (For i =1), 0.06 (for i =2)
per year
Probability of viral transmission during
acute phase, pac
0.85 Per contact
Probability of viral transmission during
chronic phase, pch
0.15 Per contact
Probability of clearing the wild-type
virus, pwt
0.85
Success state of the decoy virus, s 0 (Successful), 1 (unsuccessful)
Probability of clearing the virus
evolving decoy molecules, pdec ,s
0 (For s=0), 0.5 (for s=1)
Immunity time, t i 10 years
Acute infection time, t inf 4 weeks
VIRUS PARAMETERS
Virus mutation rate, µv d 0.0001 Per week
INITIAL CONDITIONS
Initial population size, N init 4500 Individuals
KIR initial diversity (SRI) 5–10 (1 Allele per locus)
aThe death and birth rate parameters are age-dependent and have been chosen
according to a human population (33). For a full description of the age-dependency
of birth and death rate, see Ref. (28).
bThe choice to use 16-bit strings represents a large enough theoretical repertoire
of 65,536 sequences.
cThe parameters used for the infection are chosen to maintain the epidemic.
Changing the length of the acute phase or the probabilities of clearance do not
affect our results on the evolution of the NKRs qualitatively (results not shown).
dWe manually switch on the mutation of the viruses at specific points in time, and
after that the mutation rate determines the waiting time for the mutant to arrive.
The mutant viruses appear in a short time scale and once the virus has spread in
the population, mutation does not occur anymore. Since we analyze the genetic
diversity long after the arrival of the virus, changes in mutation rate should not
affect the outcome.
individuals are able to control the virus (Figure 4B; red dashed
lines). The population size decreases to 60% of the carrying
capacity, and is therefore fitter than in those simulations con-
sidering only iNKRs (Figures 4A–C). Thus, aNKRs provide a
better initial protection than iNKRs. Accordingly, the number of
recovered individuals and thereby the total population increases
rapidly, reflecting their fast recovery against viruses evolving decoy
proteins.
The higher protection of aNKRs compared to iNKRs can be
explained by the initial specificity. Because we initialize all popula-
tions with intermediate specificity, individuals carrying only aNKR
are initially better protected (Figure 2). Nevertheless, aNKRs also
evolve to be more specific (Figure 4E; black lines). At the end of
the simulation, aNKRs recognize on average approximately 35%
of all MHC molecules, and hence decoys in the population. Taken
together, our agent-based model reveals that iNKRs need to be
more specific than aNKRs to protect during an infection with
a CMV-like virus, confirming the results from our probabilistic
model.
Note that we do not explore all possible loci number in the
agent-based model. To save computational time, we test the evo-
lution of the specificity given a fixed loci number of NKRs.
Populations carrying 10 NKR loci correspond to 20 NKRs in the
probabilistic model, where the protection is maximal at very high
specificity values for iNKR, and intermediate values for aNKR.
These values correspond indeed to the specificity values that the
populations evolve in our simulations. We carried out additional
simulations for 5 and 15 NKR loci, the results of which confirmed
the predictions of the mathematical model (results not shown).
POPULATIONS HAVING ONLY aNKRs EVOLVE A LARGER NKR
POLYMORPHISM THAN POPULATIONS WITH ONLY iNKRs
Our probabilistic model predicts that the protection by iNKRs
and aNKRs increases with the number of receptors per individual
(Figure 2), because a large receptor number increases the chance
of a host carrying very specific NKRs to have licensed receptors.
This observation suggests that heterozygous hosts should have an
advantage over homozygotes. We therefore hypothesized that het-
erozygous advantage must be selecting novel NKRs in our agent-
based model, driving polymorphism of NKRs in the population.
To measure the polymorphism at population level, we use the
Simpson’s reciprocal index (SRI, see Materials and Methods). The
SRI is a diversity measure that is equal to the total number of NKRs
if they are equally distributed in the population, whereas the SRI is
lower than that in a population where some alleles dominate (34).
The initial polymorphism of aNKRs (i.e., SRI= 10) increases
over time (Figure 4G; black line), reflecting that a high number
of aNKRs provides indeed an advantage. But surprisingly, this is
not the case for iNKRs, where the diversity decreases to SRI= 7.
Because the agent-based model considers a limited number of
MHC molecules in the population, the specificity that the iNKRs
evolve in the simulations is lower than that observed in the analyt-
ical model (i.e., pi,simulations≈ 0.18 compared to pi,analytical= 0.10)
(see Figure 2). With this specificity value that is slightly lower than
expected, all haplotypes tend to cover the entire (finite) MHC
space, making it possible to have at least one licensed receptor. As
a result, these populations can be well protected with a lower num-
ber of receptors. Therefore, there is little heterozygous advantage
in populations having only iNKRs, resulting in a low level of poly-
morphism. Thus, the agent-based model finds a different solution
for an optimal protection: it evolves contracted haplotypes (i.e.,
composed only of seven receptors) with slightly less specific iNKRs
than expected.
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FIGURE 4 | Agent-based model confirms probabilistic model. (A) A host
population having only iNKRs was inoculated with a wild-type virus (green
lines) after a period of t =5000 years (green solid lines show the chronically
infected individuals and the dashed lines the immune individuals). Ten
thousand years after the initial epidemic (i.e., t 1), we allowed for the
evolution of decoy viruses (red lines). During the wild-type infection, most
individuals recover (dashed green line). In contrast, almost none of the
individuals are initially capable of clearing a CMV-like infection (red dashed
line), resulting in a large decrease of the total population size (black line).
(B) A host population having only aNKRs is initially better protected against
decoy viruses, resulting in a higher fraction of the population clearing the
infection, and a lower decrease of the total population size. (A,B) Show
single representative simulations. (C) The average population size during the
initial spread of decoy viruses (t 1) is lower than that at the end of the
simulations (i.e., t 2 =3 million years), indicating that over time, the
populations learn to cope with the viral infection. Individuals in simulations
considering only aNKRs (black) are initially better protected than those in
simulations considering only iNKRs (red). In these simulations, all hosts
carry only one MHC locus. (D) The initial advantage that aNKRs have over
iNKRs receptors decreases in simulations considering two MHC loci per
individual. (E) The probability of iNKRs recognizing any random MHC
molecule in the population decreases over time (red line), indicating that
more specific receptors are being selected for. In contrast, aNKRs (black
line) do not evolve such high degree of specificity. (F) aNKRs evolve to
become more specific in simulations where individuals have two MHC loci.
(G) The degree of NKR polymorphism (expressed as the SRI score)
increases in time, as a result of the evolved higher specificity. (H) SRI score
in simulations considering two MHC loci. In (C,D), the boxes represent the
interquartile range, and the thick horizontal lines the median out of ten
simulations (**represent p values<0.005 and were calculated using the
Mann–Whitney U test). In (E–H), the solid lines represent the average out of
ten simulations, and the dashed lines are the standard deviation.
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Table 2 | Levels of protection against a decoy virus in the agent-based
model.
No. of aNKRbinding=0 No. of aNKRbinding>0
No. of iNKRbinding=0 pdec ,1 pdec ,1
No. of iNKRbinding >0 pdec ,0 pdec ,1
aNKRbinding and iNKRbinding refer to the number of iNKRs and aNKRs binding the
decoy molecule, respectively. The receptors here are considered to be licensed.
PROTECTION DEPENDS ON THE NUMBER OF MHC LOCI
To confirm our results concerning the dependency on MHC loci
number, we also perform simulations with individuals having two
MHC loci. An increasing number of MHC loci has a large effect
on the protection provided by aNKRs. Although these populations
are initialized with intermediate specific NKRs, the initial protec-
tion is lower than in the population carrying only one MHC locus
(Figure 4D). For better protection, a higher specificity is required,
and the selection for more specific aNKRs is stronger in these
simulations (Figure 4F). As a result of the higher specificity, a
larger number of receptors per haplotype are necessary to become
licensed and to recognize the foreign decoy molecules. There-
fore, the advantage of heterozygotes over homozygotes is larger in
these populations, resulting in a higher degree of polymorphism
(Figure 4H).
The protection and evolution of iNKRs is less sensitive to the
number of MHC loci per individual. Like in the simulations con-
sidering one MHC locus, we observe a recovery of the population
as more specific receptors are evolving (Figures 4D,F). Because the
total number of MHC alleles is larger in populations having two
MHC loci, more iNKRs per haplotype are necessary to have at least
one licensed receptor. Hence, the total SRI score is higher in these
simulations, than in the case of single MHC locus (Figures 4G,H;
red line).
BASIN OF ATTRACTION: MIXED HAPLOTYPES CONTAINING A
MAJORITY OF aNKRs
Finally, we performed simulations of populations having both
iNKRs and aNKRs, in which we allow for the evolution of the
specificity and also the receptor type. The initial specificity values
for both receptor types was intermediate (i.e., p≈ 0.4) and we ini-
tialized the genotypes with a random number of activating and
inhibitory receptors.
After the appearance of decoy viruses, the populations suf-
fered similar effects to those having only iNKRs and aNKRs. The
population size decreases dramatically at first, and with time it
recovers. The final population size is higher than in the simu-
lations considering only one type of receptor, approaching 70%
of the carrying capacity (Figure 5A) because mixed haplotypes
protect better than only one type of receptors. At the end of the
simulations, we observe more aNKRs than iNKRs per haplotype
(Figure 5B), i.e., the final haplotypes are composed on average
of 6 aNKRs and 4 iNKRs. In agreement with the predictions of
the analytical model, both receptor types evolve high specificity
(i.e., p≤ 0.35), and a high polymorphism (Figures 5C,D). Sum-
marizing, the agent-based model confirms the prediction of the
probabilistic model.
CONCLUSION AND DISCUSSION
Our mathematical model predicts the optimal protection level
provided by inhibiting and activating NKRs against viruses
expressing MHC-like molecules. Haplotypes composed only of
iNKRs detect the viral infection within a small range, requiring
high specificity and large haplotype size. In contrast, the maximal
protection is reached for intermediate specificity values and at a
smaller haplotype size in individuals having only aNKRs. Mixed
haplotypes, i.e., haplotypes carrying both iNKRs and aNKRs offer
the highest protection.
All these results are dependent on the number of MHC loci
per individual. With increasing MHC loci, aNKRs lose their abil-
ity to become licensed and thus provide little or no protection.
In contrast, haplotypes composed only of iNKR have a higher
chance of having licensed receptors when the number of MHC
loci is increased. In this case, the protection level is maximal
already with a contracted NKR haplotype. Thus, there seem to
be several combinations of MHC–NKR genotypes that provide
maximal protection. A high protection is reached with a simple
MHC complex and a high number of NKR genes. With increasing
complexity of the MHC, a contracted NK complex is sufficient to
render protection. These last results are particularly interesting, as
they provide a possible explanation of the differences in KIR and
MHC gene content across primate species (35), and the expansion
of new KIR lineages corresponding to the contraction of the MHC
gene complex, thus illustrating the co-evolution of MHC class I
and KIRs (36).
The model described here is inspired by viruses evolving decoys.
However, its main outcome,namely the requirement for specificity,
might be more general than the defense against such decoy viruses.
Studies have shown that viral infections can change the repertoire
of peptides presented by MHC class I molecules (37), and that
these different peptides affect the NKR–MHC interactions, per-
turbing the binding of iNKRs and leading to NK cell activation
(38). In such cases, specific recognition of the changes in pep-
tide repertoire by NK cells seems advantageous for the host. Also,
the specificity ranges obtained in our model for mixed haplotypes
(Figure 3E) are similar to those observed in reality, with iNKRs
having a specificity of 0.2. This corresponds to the four mutu-
ally exclusive epitopes that have been detected so far for inhibitory
KIRs in humans: HLA-A11, -Bw4, -C1, and -C2.
The exact role of aNKRs remains intriguing. Since only a
few aNKRs tend to recognize MHC class I molecules (39), we
speculate that aNKRs could specifically recognize new ligands
expressed upon viral infection (e.g., decoy molecules or stress
ligands). Our model predicts that to face the challenge of not rec-
ognizing self but specifically recognize foreign antigens, aNKRs
do not need to be so specific. Indeed, the haplotype provid-
ing the highest protection is a combined haplotype composed
of more aNKRs than iNKRs, which disagrees with the most pri-
mate KIR haplotypes (36). Most primate NKRs are inhibitory,
and activating receptors have been linked to selection pres-
sure induced by reproduction (36). Our model predicts that
aNKRs should evolve to an intermediate specificity upon CMV-
like infections. However, not many activating ligands have been
identified yet, and it remains puzzling what other roles aNKRs
might play.
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FIGURE 5 | Mixed haplotypes offer the highest protection. A host
population having iNKRs and aNKRs was inoculated with a wild-type
virus after a period of t =5000 years; we allowed for the evolution of
decoy viruses 10,000 years after the initial epidemic (i.e., t 1). (A) The
population size during the initial spread of decoy viruses (t 1) is lower than
that at the end of the simulations (i.e., t 2 =3 million years), indicating
that over time, the population recovers from the viral infection. (B) The
initial haplotype is composed of five iNKRs and five aNKRs. The number
of aNKRs and iNKRs per haplotype varies over time, resulting in a
selection for haplotypes with a larger activating potential. (C) The
probability of NKRs recognizing any random MHC molecule in the
population, decreases over time, indicating that more specific receptors
are being selected for. (D) The degree of NKR polymorphism (expressed
as the SRI score) increases in time, as a result of the heterozygote
advantage due to the evolved higher specificity. Averages are taken out
of ten different simulations. In (A), the boxes represent the interquartile
range, and the thick horizontal lines the median (**represent p values
<0.005, and were calculated using the Mann–Whitney U test). In
(B–D), the solid lines represent the average out of ten simulations, and
the dashed lines are the standard deviation.
The expansion of NKR superfamilies, presumably in order to
gain resistance against pathogens, illustrates the high evolutionary
complexity of NKRs. We aimed to fully understand the effects of a
single possible driving force of this evolutionary process, namely
that of a viral encoded MHC-like molecule. Therefore, we focused
on modeling only the evolution of NKRs in a simple model, which
requires simplifying assumptions. For instance, we fixed MHC
polymorphism despite the evidence of the co-evolution between
MHC class I and KIRs (35, 36). Given their different evolutionary
timescales, i.e., that MHC molecules are older than both Ly49 and
KIRs, we chose to model the expansion and contraction of NKR
systems within an already existing MHC diversity. Additionally,
we assumed that decoy viruses down-regulate the expression of
all MHC molecules in the host. Even though we do not expect
selective MHC down-regulation to affect the evolution of aNKRs
(since activating receptors cannot detect missing-self), the evolu-
tion of iNKRs might be affected because more licensed iNKRs will
be necessary to recognize a virus that down-regulates only one of
the host’s MHC-I molecules. Note that if the licensed repertoire
of iNKRs is larger, these receptors should be even more specific
to avoid being “fooled” by the decoy molecule. The exact effect of
selective MHC down-regulation on the specificity of iNKRs is an
open interesting question, which we are currently working on.
Other simplifying assumptions were also necessary, such as
considering a global NKR repertoire and ignoring the synergy
between NKRs or the direct interaction between immune cells.
Additionally, we ignored mutational operators that conserve simi-
larity between pre- and post-mutation receptors (e.g., point muta-
tions), as we only model mutations that significantly change recep-
tor functionality. Including point mutations, did not affect the
results qualitatively (results not shown), however a longer evolu-
tionary time was necessary to approach the same solution of speci-
ficity. Overall, since our main results are of a qualitative nature, it
seems unlikely that relaxing any of these assumptions would affect
our main results. Note also that our agent-based model is inspired
on humans and KIRs, with the advantage of having realistic para-
meters for processes like birth and death. However, the model can
be generalized to other species, and qualitatively it represents a
model of the evolution of the expansion of the NKR complex.
All our analytical results were consistent with the agent-based
model and our analysis allowed us to quantify the protection
against an infection for both receptor types. It confirmed our
previous results that iNKRs should become specific enough (28).
Our new approach has shed light into the possible contribution
that each receptor type confers upon infection, and allowed us to
conclude that mixed haplotypes render the best protection.
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MATERIALS AND METHODS
AGENT-BASED MODEL
The agent-based model consists of two types of actors (hosts and
viruses) and three events (birth, death, and infection). This model
is virtually identical to the one published in Ref. (28). Briefly, we
screen all hosts in a random order during each time step of 1 week,
and confront them to one of the randomly chosen events. Hosts
age over time and at the end of each time step, their age, infec-
tion state, and type of infection is updated. This cycle is repeated
for two million years to simulate long term evolution. All model
parameters are given in Table 1.
We model simplified diploid individuals, carrying gene com-
plexes for NKR and MHC class I. For simplicity, we consider
15 MHC alleles per locus, resembling the most common HLA
alleles in the European population (40). NKRs and their ligands
are modeled with randomly generated bit strings as a simplified
representation of amino acids (41). If the longest adjacent com-
plementary match between two strings exceeds a threshold L, we
allow for the receptor to interact with its ligand. Thus, the thresh-
old L determines the specificity of each receptor: a receptor with
a small L value will be very degenerate and the probability of
a random NKR to recognize a random MHC molecule will be
p≈ 1. In contrast, a receptor with a large L value will be specific,
and accordingly, the probability of this receptor binding any MHC
molecule in the population will be p∼ 0 [for a detailed description,
see Ref. (28)].
RECEPTOR TYPES
In the present model, we allow for the evolution of aNKRs.
When a novel NKR is generated, a random L value between 1
and 16 is assigned to it, and its type (i.e., whether it is activat-
ing or inhibitory) is also randomly chosen. Thus, each receptor
has its particular specificity and functionality. Receptors with
L values larger than 13 will usually not recognize any MHC
molecules in the population, and are typically not functional.
Genes encoding such non-functional NKRs are considered to be
pseudogenes. Haplotypes containing pseudogenes are effectively
shorter than haplotypes composed of fully functional NKRs. Thus,
we can model the contraction and expansion of the NKR gene
complex.
VIRAL INFECTIONS
In our simulations, we consider one wild-type virus and several
“decoy viruses,” i.e., viruses expressing MHC decoys. Each virus
comes with a viral load, which is implemented as an increase
of the host’s death rate, VLi depending on the infection state i
(see Table 1), and a probability of clearing the infection pwt and
pdec,s for the wild-type and the decoy viruses, respectively. A decoy
virus down-regulates the expression of all MHC molecules in that
host, and encodes one MHC-like molecule. The evolution of decoy
molecules is modeled by allowing the virus to adopt a randomly
selected MHC molecule from its host with a rate µv. The virus
keeps this decoy for the rest of the simulation. Because we fix the
MHC polymorphism to 15 alleles per locus, the maximal num-
ber of decoy proteins that can evolve in the population is 15
for the simulations considering 1 MHC locus, and 30 for those
considering two MHC loci.
We consider different levels of protection against a decoy virus,
depending on the success of the virus to escape the NK cell
response, s. If at least one of the licensed iNKR binds to the decoy
molecule, there will be an inhibitory signal, the host will not be
able to detect “missing-self,” and the decoy virus will be successful.
Similarly, if none of the licensed aNKRs recognizes the decoy mol-
ecule, the decoy virus will evade the NK cell response. Thus, none
of the iNKRs or at least one aNKRs should bind the decoy mole-
cule to render protection (Table 2). We model the immune escape
by setting the probability of clearing the infection to zero, letting
the host become chronically infected. In the case that a decoy is
not successful, the host will be able to detect “missing-self.” Since
this virus is nevertheless able to evade the response from T cells
(due to the MHC down-regulation), the probability of clearing
the infection is lower than that of the wild-type virus (pwt= 0.85).
The resulting probability of clearing the infection is described by:
pdec ,s =
{
0, if s = 0 (successful decoy)
0.5, if s = 1 (unsuccessful decoy) . (5)
The rest of the parameters defining the infection dynamics and
immune escape of the decoy viruses (i.e., time of infection, immu-
nity time, and transmission probabilities) were set like in Ref. (28)
and are described in Table 1.
MUTATION
During each birth event, NKRs undergo mutation with a prob-
ability, µ. To decrease computation time, we model mutation by
randomly creating a new receptor with its particular specificity and
signaling type. We do not consider other mutational operators,
e.g., point mutations, recombination, deletion, or duplication.
We first perform simulations where only the specificity can
evolve (i.e., a random value L is assigned to each new receptor),
while the receptor type remains fixed. Hereby, we are able to com-
pare what the basin of attraction for the specificity will be, if a
population has only aNKRs or only iNKRs. We also simulate pop-
ulations with mixed haplotypes, by allowing the receptor type to
mutate.
NK CELL EDUCATION
During the birth event, an NK cell education process takes place.
Like in our probabilistic model explained above, iNKRs which
recognize at least one of the MHC molecules within one individ-
ual, and aNKRs that fail to recognize all of the MHC molecules
within the host, are set to be licensed. In our model, only the
licensed repertoire of NKRs will participate in an NK cell response
(Figure 1).
MODEL INITIALIZATION
The model is initialized with a host population of 4500 hosts, with
random ages between 1 and 70 years corresponding to a uniform
age distribution. After approximately 10 host generations, this age
distribution corresponds to more modern age distributions with
the majority of individuals having an age between 15 and 60.
At the start of every simulation, a gene pool for MHC alle-
les is generated, the size of which depends on the number of
MHC loci per individual. It consists of 15 alleles in simulations
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considering one MHC locus per individual, and of 30 alleles in
those simulations considering two MHC loci per individual. To
create the initial genome of each individual, MHC genes were ran-
domly drawn from the pool, while ten NKRs with intermediate
specificity (2≤ L≤ 4, i.e., p≈ 0.4) were generated. Thus, the initial
haplotypes did not contain any pseudogenes. In the simulations
considering mixed NKR haplotypes, the initial genes can be both
activating and inhibitory. The type of each receptor was randomly
chosen as explained above, resulting in approximately 50% of the
receptors being activating. All individuals were initialized with the
same NKR haplotype, but with different MHC genes.
GENETIC DIVERSITY
The Simpson’s Index is a measurement of diversity that can be
interpreted as the probability that two randomly chosen receptors
from two random hosts in the population are identical (34). The
reciprocal of the Simpson’s Index defines a “weighted” diversity.
The SRI was calculated as follows: SRI = 1∑N
i=1 fi 2
, where fi is the
frequency of the receptor i over all NKRs in the population, and
N is the total number of unique NKRs.
IMPLEMENTATION
The model was implemented in the C++ programing language.
We considered populations with haplotypes composed of only
aNKRs, only iNKRs, or both. In every scenario, we compared the
effects of one or two MHC loci per individual. For each of these
settings, we performed ten simulations for 2 million years. The
code is available upon request.
ACKNOWLEDGMENTS
We thank Chris van Dorp, Leïla Perie, and Hanneke van Deutekom
for helpful discussions and carefully reading the manuscript. We
also thank Oussama Jarrousse and Johannes Textor for their tech-
nical support during the development of the code. This work
was financially supported by the CLS program of the Netherlands
Organization for Scientific Research (NWO), grant 635.100.025.
This study was also supported by the “Virgo consortium,” funded
by the Dutch government (project number FES0908) and by the
“Netherlands Genomics Initiative (NGI)” (project number 050-
060-452). The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
REFERENCES
1. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev
Immunol (2008) 8(4):259–68. doi:10.1038/nri2276
2. Lanier LL. NK cell recognition. Annu Rev Immunol (2005) 23:225–74. doi:10.
1146/annurev.immunol.23.021704.115526
3. Ljunggren HG, Kärre K. In search of the “missing self”: MHC molecules and
NK cell recognition. Immunol Today (1990) 11(7):237–44. doi:10.1016/0167-
5699(90)90097-S
4. O’Callaghan CA. Molecular basis of human natural killer cell recognition of
HLA-E (human leukocyte antigen-E) and its relevance to clearance of pathogen-
infected and tumour cells. Clin Sci (Lond) (2000) 99(1):9–17. doi:10.1042/
CS19990334
5. Braud VM, Allan DS, O’Callaghan CA, Söderström K, D’Andrea A, Ogg GS, et al.
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature
(1998) 391(6669):795–9. doi:10.1038/35869
6. Shum BP, Flodin LR, Muir DG, Rajalingam R, Khakoo SI, Cleland S, et al. Con-
servation and variation in human and common chimpanzee CD94 and NKG2
genes. J Immunol (2002) 168(1):240–52.
7. Trowsdale J, Barten R, Haude A, Stewart CA, Beck S, Wilson MJ. The genomic
context of natural killer receptor extended gene families. Immunol Rev (2001)
181:20–38. doi:10.1034/j.1600-065X.2001.1810102.x
8. Moesta AK, Parham P. Diverse functionality among human NK cell receptors for
the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front Immunol
(2012) 3:336. doi:10.3389/fimmu.2012.00336
9. Jiang W, Johnson C, Jayaraman J, Simecek N, Noble J, Moffatt MF, et al. Copy
number variation leads to considerable diversity for B but not A haplotypes
of the human KIR genes encoding NK cell receptors. Genome Res (2012)
22(10):1845–54. doi:10.1101/gr.137976.112
10. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and
adaptive immunity. Annu Rev Immunol (2002) 20:217–51. doi:10.1146/annurev.
immunol.20.092501.134942
11. Kelley J, Walter L, Trowsdale J. Comparative genomics of natural killer cell
receptor gene clusters. PLoS Genet (2005) 1(2):e27. doi:10.1371/journal.pgen.
0010027
12. Guethlein LA, Older Aguilar AM, Abi-Rached L, Parham P. Evolution of killer
cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype
reveals expansion of lineage III KIR associated with the emergence of MHC-C.
J Immunol (2007) 179(1):491–504.
13. Anfossi N, André P, Guia S, Falk CS, Roetynck S, Stewart CA, et al. Human
NK cell education by inhibitory receptors for MHC class I. Immunity (2006)
25(2):331–42. doi:10.1016/j.immuni.2006.06.013
14. Wilhelm BT, Gagnier L, Mager DL. Sequence analysis of the ly49 cluster in
C57BL/6 mice: a rapidly evolving multigene family in the immune system.
Genomics (2002) 80(6):646–61. doi:10.1006/geno.2002.7004
15. Wilhelm BT, Mager DL. Rapid expansion of the Ly49 gene cluster in rat.
Genomics (2004) 84(1):218–21. doi:10.1016/j.ygeno.2004.01.010
16. Körner C,Altfeld M. Role of KIR3DS1 in human diseases. Front Immunol (2012)
3:326. doi:10.3389/fimmu.2012.00326
17. Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, et al. Copy
number variation of KIR genes influences HIV-1 control. PLoS Biol (2011)
9(11):e1001208. doi:10.1371/journal.pbio.1001208
18. Martin MP, Gao X, Lee J-H, Nelson GW, Detels R, Goedert JJ, et al. Epistatic
interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat
Genet (2002) 31(4):429–34. doi:10.1038/ng934
19. Zhi-Ming L, Yu-lian J, Zhao-lei F, Chun-xiao W, Zhen-fang D, Bing-chang Z,
et al. Polymorphisms of killer cell immunoglobulin-like receptor gene: possi-
ble association with susceptibility to or clearance of hepatitis B virus infection
in Chinese Han population. Croat Med J (2007) 48(6):800–6. doi:10.3325/cmj.
2007.6.800
20. López-Vázquez A, Rodrigo L, Martínez-Borra J, Pérez R, Rodríguez M, Fdez-
Morera JL, et al. Protective effect of the HLA-Bw4I80 epitope and the killer cell
immunoglobulin-like receptor 3DS1 gene against the development of hepato-
cellular carcinoma in patients with hepatitis C virus infection. J Infect Dis (2005)
192(1):162–5. doi:10.1086/430351
21. Besson C, Roetynck S, Williams F, Orsi L, Amiel C, Lependeven C, et al. Asso-
ciation of killer cell immunoglobulin-like receptor genes with Hodgkin’s lym-
phoma in a familial study. PLoS One (2007) 2(5):e406. doi:10.1371/journal.
pone.0000406
22. Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A, et al. Maternal
activating KIRs protect against human reproductive failure mediated by fetal
HLA-C2. J Clin Invest (2010) 120(11):4102–10. doi:10.1172/JCI43998
23. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, et al. Recog-
nition of a virus-encoded ligand by a natural killer cell activation receptor. Proc
Natl Acad Sci U S A (2002) 99(13):8826–31. doi:10.1073/pnas.092258599
24. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of
cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002)
296(5571):1323–6. doi:10.1126/science.1070884
25. Abi-Rached L, Parham P. Natural selection drives recurrent formation of activat-
ing killer cell immunoglobulin-like receptor and Ly49 from inhibitory homo-
logues. J Exp Med (2005) 201(8):1319–32. doi:10.1084/jem.20042558
26. Arase H, Lanier LL. Virus-driven evolution of natural killer cell receptors.
Microbes Infect (2002) 4(15):1505–12. doi:10.1016/S1286-4579(02)00033-3
27. Sun JC, Lanier LL. The natural selection of herpesviruses and virus-specific NK
cell receptors. Viruses (2009) 1(3):362. doi:10.3390/v1030362
28. Carrillo-Bustamante P, Kesmir C, de Boer RJ. Virus encoded MHC-like
decoys diversify the inhibitory KIR repertoire. PLoS Comput Biol (2013)
9(10):e1003264. doi:10.1371/journal.pcbi.1003264
Frontiers in Immunology | T Cell Biology January 2014 | Volume 5 | Article 20 | 12
Carrillo-Bustamante et al. Quantifying the protection of NKRs
29. Elliott JM, Yokoyama WM. Unifying concepts of MHC-dependent natural
killer cell education. Trends Immunol (2011) 32(8):364–72. doi:10.1016/j.it.
2011.06.001
30. Chalifour A, Scarpellino L, Back J, Brodin P, Devèvre E, Gros F, et al. A role for
cis interaction between the inhibitory Ly49A receptor and MHC class I for nat-
ural killer cell education. Immunity (2009) 30(3):337–47. doi:10.1016/j.immuni.
2008.12.019
31. Sun JC, Lanier LL. Tolerance of NK cells encountering their viral ligand during
development. J Exp Med (2008) 205(8):1819–28. doi:10.1084/jem.20072448
32. Fauriat C, Ivarsson MA, Ljunggren HG, Malmberg KJ, Michaëlsson J. Educa-
tion of human natural killer cells by activating killer cell immunoglobulin-like
receptors. Blood (2010) 115(6):1166–74. doi:10.1182/blood-2009-09-245746
33. Carnes BA, Holden LR, Olshansky SJ, Witten MT, Siegel JS. Mortality par-
titions and their relevance to research on senescence. Biogerontology (2006)
7(4):183–98. doi:10.1007/s10522-006-9020-3
34. Simpson E. Measurement of diversity. Nature (1949) 163:688. doi:10.1038/
163688a0
35. Sambrook JG, Bashirova A, Palmer S, Sims S, Trowsdale J, Abi-Rached L,
et al. Single haplotype analysis demonstrates rapid evolution of the killer
immunoglobulin-like receptor (KIR) loci in primates. Genome Res (2005)
15(1):25–35. doi:10.1101/gr.2381205
36. Parham P, Moffett A. Variable NK cell receptors and their MHC class I ligands
in immunity, reproduction and human evolution. Nat Rev Immunol (2013)
13(2):133–44. doi:10.1038/nri3370
37. Hickman HD, Luis AD, Bardet W, Buchli R, Battson CL, Shearer MH, et al.
Cutting edge: class I presentation of host peptides following HIV infection.
J Immunol (2003) 171(1):22–6.
38. Fadda L, O’Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, Carring-
ton M, et al. Common HIV-1 peptide variants mediate differential binding of
KIR3DL1 to HLA-Bw4 molecules. J Virol (2011) 85(12):5970–4. doi:10.1128/
JVI.00412-11
39. Moesta AK, Graef T, Abi-Rached L, Older Aguilar AM, Guethlein LA, Parham
P. Humans differ from other hominids in lacking an activating NK cell receptor
that recognizes the C1 epitope of MHC class I. J Immunol (2010) 185(7):4233–7.
doi:10.4049/jimmunol.1001951
40. Meyer D, Singe R, Mack S, Lancaster A, Nelson M, Erlich H, et al. Single
locus polymorphism of classical HLA genes. In: Hansen JA, editor. Immuno-
biology of the Human MHC: Proceedings of the 13th International Histocom-
patibility Workshop and Conference. (Vol. 1), Seattle, WA: IHWG Press (2007).
p. 653–704.
41. Farmer JD, Packard NH, Perelson AS. The immune system, adaptation, and
machine learning. Physica D (1986) 22:187–204. doi:10.1016/0167-2789(86)
90240-X
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 25 September 2013; accepted: 15 January 2014; published online: 30 January
2014.
Citation: Carrillo-Bustamante P, Kes¸mir C and de Boer RJ (2014) Quantifying the pro-
tection of activating and inhibiting NK cell receptors during infection with a CMV-like
virus. Front. Immunol. 5:20. doi: 10.3389/fimmu.2014.00020
This article was submitted to T Cell Biology, a section of the journal Frontiers in
Immunology.
Copyright © 2014 Carrillo-Bustamante, Kes¸mir and de Boer. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
www.frontiersin.org January 2014 | Volume 5 | Article 20 | 13
Carrillo-Bustamante et al. Quantifying the protection of NKRs
APPENDIX
GLOBAL REPERTOIRE OF LICENSED NKRs
Instead of considering individual NK cells expressing a tuned set
of NKRs, we model a global repertoire of “licensed” NKRs in
each host. Hereby, we assume that the expression of at least one
“licensed” receptor is sufficient to educate NK cells, and that those
functional NK cells can become activated upon viral infection.
This assumption needs further explanation.
If an aNKR recognizes some self-molecule (or self-MHC), all
developing NK cells expressing that receptor should additionally
express at least one iNKR recognizing self to prevent self-reactivity.
As a consequence, all NK cells expressing that aNKR should never
become activated, even if a virus encodes a ligand which engages
that aNKR. Therefore, we call such an aNKR “unlicensed”: it will
never contribute to detect a viral infection. In contrast, if an aNKR
that does not recognize any self-molecule, all developing NK cells
expressing that receptor will not be influenced by it, and these
cells will express other iNKRs and aNKRs that balance their self-
reactivity. NK cells expressing that aNKR will become activated
when a virus expressing its ligand engages that aNKR. Therefore
we call such an aNKR“licensed.”Any NK cell expressing this aNKR
should breach its activation threshold, expand, and protect, when
the ligand is present.
Now consider an iNKR that recognizes some self-MHC. All
developing NK cells expressing that receptor will be tuned to bal-
ance its self-reactivity. As a consequence, all NK cells expressing
that iNKR should become activated when a virus down-regulates
this particular MHC. Therefore, we call such an iNKR “licensed”:
it detects MHC down-regulation. However, for an iNKR that does
not recognize any self-MHC, the developing NK cells express-
ing that receptor will not be influenced by that iNKR. Conse-
quently, these cells will express other iNKRs and other aNKRs in
order to balance their self-reactivity. Therefore, NK cells express-
ing that iNKR will not become activated by this iNKR when a
virus down-regulates self-MHC. Therefore, we call such an iNKR
“unlicensed”: it would never contribute to the detection of virus
infected cells.
What happens with the NK cells expressing such an unli-
censed iNKR if it happens to recognize something else on
virus infected cells, e.g., a decoy? Then the iNKR should deliver
an extra inhibitory signal to those cells. Consequently, these
NK cells cannot expand and protect, even if their other iNKR
detect MHC down-regulation, or if their other aNKR detect a
new ligand. Hence, such an unlicensed iNKR will not protect,
and can be considered to be non-functional at the repertoire
level.
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